The results provide evidence supporting a role for Lphn3 in modulating inhibitory control and working memory, and suggest additional research evaluating the role of Lphn3 in the manifestation of EDs more broadly is warranted. The gene discussed is ADGRL3; the disease is Ehlers-Danlos syndrome.